Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 KRAS mutations and their correlation with survival of patients with advanced pancreatic cancer.

× No keyword cloud information.

6 in total

Review 1. Role of endoscopic ultrasound in the molecular diagnosis of pancreatic cancer.

Authors: Barbara Bournet; Marion Gayral; Jérôme Torrisani; Janick Selves; Pierre Cordelier; Louis Buscail
Journal: World J Gastroenterol Date: 2014-08-21 Impact factor: 5.742

2. KRAS mutations in pancreatic circulating tumor cells: a pilot study.

Authors: Birte Kulemann; Andrew S Liss; Andrew L Warshaw; Sindy Seifert; Peter Bronsert; Torben Glatz; Martha B Pitman; Jens Hoeppner
Journal: Tumour Biol Date: 2015-12-18

3. Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study.

Authors: Agata I Rembielak; Pooja Jain; Andrew S Jackson; Melanie M Green; Gillian R Santorelli; Gillian A Whitfield; Adrian Crellin; Angel Garcia-Alonso; Ganesh Radhakrishna; James Cullen; M Ben Taylor; Ric Swindell; Catharine M West; Juan Valle; Azeem Saleem; Patricia M Price
Journal: Transl Oncol Date: 2014-02-01 Impact factor: 4.243

Review 4. K-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis.

Authors: Tao Li; Yuanting Zheng; Hong Sun; Rongyuan Zhuang; Jing Liu; Tianshu Liu; Weimin Cai
Journal: Med Oncol Date: 2016-05-25 Impact factor: 3.064

5. STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth.

Authors: Jingjing Gong; Amanda R Muñoz; Daniel Chan; Rita Ghosh; Addanki P Kumar
Journal: Oncotarget Date: 2014-05-15

6. Intraductal papillary mucinous neoplasms of the pancreas: Clinical association with KRAS.

Authors: Xiao Yan Chang; Yan Wu; Yuan Li; Jing Wang; Jie Chen
Journal: Mol Med Rep Date: 2018-04-12 Impact factor: 2.952

6 in total